Ligand Pharmaceuticals Inc. (LGND) Stock Price

LGNDStock
$280.49+75.35%52W
Market Cap$5.59B
P/E46.98x
PEG Ratio1.53
Div yield
Beta1.20

LGND Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)36.48%
Price vs S&P 500 (4W)-5.50%
PEG Ratio1.53
VGM Score52.31
P/E Ratio (Annual)46.98x

LGND Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026$1.95$2.37+21.48%(+$0.42)
Q1 2026$1.80$1.63-9.61%(-$0.17)
Q4 2025$1.50$2.02+34.92%(+$0.52)
Q3 2025$1.93$3.09+60.46%(+$1.16)
Q2 2025$1.42$1.60+12.56%(+$0.18)

LGND Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.29
4.29
4.29
4.33

Industry Peers — Pharmaceuticals(570)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
LGNDLigand Pharmaceuticals Inc.
DCB$280.49
LLYEli Lilly & Co.DBC$1174.61
JNJJohnson & JohnsonDCB$268.04
ABBVABBVIE INC.DCB$255.48
MRKMerck & Co., Inc.DCB$148.35
NVSNovartis AGCCC$153.81
AZNAstraZeneca PLCCBC$162.70
NVONovo-Nordisk A/SBCC$45.61
ABTAbbott LaboratoriesCCC$112.47
PFEPfizer Inc.CDB$27.96
VRTXVertex Pharmaceuticals IncDCB$541.69

About Ligand Pharmaceuticals Inc.

Ligand Pharmaceuticals is a biopharmaceutical company focused on developing and acquiring drug technologies through strategic partnerships and licensing agreements. The company generates revenue from three primary sources: royalties on commercialized products, licensing and milestone payments, and sales of its proprietary Captisol platform.